U.S. National Institutes of Health, Author at ScienceBlog.com

Scientists find HIV-blocking protein in monkeys

Scientists have identified a protein that blocks HIV replication in monkey cells. Humans have a similar protein, although it is not as effective at stopping HIV, say the researchers whose work is published in this week’s issue of Nature. “Identification of this HIV-blocking factor opens new avenues for intervening in the early stage of HIV infection, before the virus can gain a toehold,” says NIAID Director Anthony S. Fauci, M.D. “The discovery also gives us critical insights about viral uncoating, a little understood step in the viral lifecycle. Basic discoveries like this provide the scientific springboard to future improvements in therapies for HIV disease.”

Monkey talk, human speech share left-brain processing

Scans have pinpointed circuits in the monkey brain that could be precursors of those in humans for speech and language. As in humans, an area specialized for processing species-specific vocalizations is on the left side of the brain, report researchers at the National Institute of Mental Health and elsewhere. An area near the left temple responded significantly more than the same area on the right only to monkey calls, not to other animal calls, human voices or various other sounds.

Non-human Molecule Is Absorbed by Eating Red Meat

A non-human, cellular molecule is absorbed into human tissues as a result of eating red meat and milk products, according to a study by researchers at the University of California, San Diego (UCSD) School of Medicine, published online the week of September 29, 2003 in Proceedings of the National Academy of Sciences. The researchers also showed that the same foreign molecule generates an immune response that could potentially lead to inflammation in human tissues.

Test will ID presence of 25 most common mutations of cystic fibrosis

“Eighty percent of all babies born in the US that have cystic fibrosis (CF) are born to parents with no previous family history.” This attention-getting quote, used frequently by an activist in the CF community, makes it powerfully clear what few people realize: that both parents did not know they would pass on to their child the life-altering CFTR gene, the gene mutated in cystic fibrosis. In fact, the Cystic Fibrosis Foundation estimates that more than 10 million Americans are unknowing, asymptomatic carriers of CF, which causes a thickening mucous to surround the lungs and serves as a catalyst for multiple, life-threatening infections throughout a lifetime.

Pretreatment increases liver transplant survival

Pretreating transplanted livers with the immune molecule interleukin-6 (IL-6) dramatically increased survival of rats receiving organs with fatty degeneration–a common condition in humans that typically reduces transplant viability. The results suggest a means of making it possible to use a higher percentage of available donor livers for transplantation in humans. With over three times as many Americans needing transplants as there are available donor livers, an effective approach to increasing the number of viable donor organs would help narrow the gap between demand and supply.

Gene Enhances Prefrontal Function at a Price

Studies of a gene that affects how efficiently the brain’s frontal lobes process information are revealing some untidy consequences of a tiny variation in its molecular structure and how it may increase susceptibility to schizophrenia. People with a common version of the gene associated with more efficient working memory and frontal lobe information processing may pay a penalty in adverse responses to amphetamine, in heightened anxiety and sensitivity to pain. Yet, another common version may slightly bias the brain toward a pattern of neurochemical activity associated with psychosis, report researchers at the National Institutes of Health (NIH).

Researchers report first evidence of cellular ‘catch bonds’

An article published this week in the journal Nature provides the first experimental evidence for an unusual molecular bonding mechanism that could explain how certain cells adhere to surfaces such as blood vessel walls under conditions of mechanical stress. Known as “catch bonds,” the adhesion mechanism displays surprising behavior, prolonging rather than shortening the lifetimes of bonds between specific molecules as increasing force is applied. Proposed theoretically nearly 15 years ago, catch bonds could help explain how the body regulates the activity of white blood cells, which must flow freely through blood vessels — yet bond to injury sites despite blood flow forces.

Gene discovery may shed light on carpel tunnel syndrome and Lou Gehrig's disease

Scientists at the National Human Genome Research Institute (NHGRI) and at the National Institute of Neurological Disorders and Stroke (NINDS) have identified the gene responsible for two related, inherited neurological disorders, and have, for the first time, directly implicated this gene and its enzyme product in a human genetic disease.

Scientists Discover Unique Source of Stem Cells: Baby teeth

Scientists report for the first time that “baby” teeth, the temporary teeth that children begin losing around their sixth birthday, contain a rich supply of stem cells in their dental pulp. The researchers say this unexpected discovery could have important implications because the stem cells remain alive inside the tooth for a short time after it falls out of a child’s mouth, suggesting the cells could be readily harvested for research.

Sloppy repair helps TB bug resist drugs

Shoddy work by a DNA-repair enzyme allows tuberculosis-causing bacteria to develop antibiotic resistance, scientists at the National Institute of Allergy and Infectious Diseases (NIAID) have discovered. Reported in the current issue of the journal Cell, the finding could lead to new ways to treat TB without risking the development of drug resistance.

Researchers Identify Gene for Premature Aging Disorder

A team led by the National Human Genome Research Institute today announced the discovery of the genetic basis of a disorder that causes the most dramatic form of premature aging, a finding that promises to shed new light on the rare disease, as well as on normal human aging. In their study, to be released online next week in the journal Nature, researchers identified the genetic mutations responsible for Hutchinson-Gilford progeria syndrome (HGPS), commonly referred to as progeria. Derived from the Greek word for old age, “geras,” progeria is estimated to affect one in 8 million newborns worldwide. There currently are no diagnostic tests or treatments for the progressive, fatal disorder.

Researchers find human body produces ozone

In what is a first for biology, a team of investigators is reporting that the human body makes ozone. The team has been slowly gathering evidence over the last few years that the human body produces the reactive gas — most famous as the ultraviolet ray-absorbing component of the ozone layer — as part of a mechanism to protect it from bacteria and fungi. “Ozone was a big surprise,” says researcher Bernard Babior. “But it seems that biological systems manufacture ozone, and that ozone has an effect on those biological systems.”

Gov't announces contract for safer smallpox vaccine

HHS Secretary Tommy G. Thompson today announced the award of two contracts totaling up to $20 million in first-year funding to develop safer smallpox vaccines. The three-year contracts were awarded to Bavarian Nordic A/S of Copenhagen, Denmark, and Acambis Inc. of Cambridge, Mass. The National Institute of Allergy and Infectious Diseases (NIAID) will administer the contracts.

Low Dose Warfarin Prevents Recurrence of Blood Clots

A study of long-term, low-dose warfarin to prevent the recurrence of the blood clotting disorders deep vein thrombosis (DVT) and pulmonary embolism resulted in such a high degree of benefit to the patients — without significant adverse effects — that the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped the study early.